Digital pathology


Direct-to-digital pathology solutions align with the industry’s focus on improving diagnostic capabilities, enhancing efficiency, and advancing the field of cancer research and treatment.


Histolix focuses on the development of a digital slide-free histopathology solution that can be deployed in both pathology labs and clinician-focused point-of-care settings. The company’s Giga Fluorescence Imitating Brightfield Imaging (FIBI) technology is a key area of evaluation and development supported by the grant.


Related Trends